The Enterprise Value as of November 2024 (TTM) for MaxCyte, Inc. (MXCT) is 355.82M

According to MaxCyte, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 355.82M. This represents a change of -14.48% compared to the average of 416.05M of the last 4 quarters.

MaxCyte, Inc. (MXCT) Historical Enterprise Value (quarterly & annually)

How has MXCT Enterprise Value performed in the past?

The mean historical Enterprise Value of MaxCyte, Inc. over the last ten years is 773.49M. The current 355.82M Enterprise Value has changed 4.50% with respect to the historical average. Over the past ten years (40 quarters), MXCT's Enterprise Value was at its highest in in the June 2021 quarter at 1.40B. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

MaxCyte, Inc. (MXCT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MaxCyte, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MaxCyte, Inc. (MXCT) Average Enterprise Value

How has MXCT Enterprise Value performed in the past?

The current Enterprise Value of MaxCyte, Inc. (MXCT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

MaxCyte, Inc. (MXCT) Enterprise Value vs. Peers

How is MXCT’s Enterprise Value compared to its peers?

MaxCyte, Inc.’s Enterprise Value is greater than Sight Sciences, Inc. (120.25M), greater than CVRx, Inc. (310.32M), greater than NeuroPace, Inc. (347.61M), greater than Rapid Micro Biosystems, Inc. (33.90M), less than CONMED Corporation (3.22B), less than OrthoPediatrics Corp. (611.40M), less than Surmodics, Inc. (554.56M), less than Integer Holdings Corporation (5.77B), greater than Pulmonx Corporation (260.62M), less than IRadimed Corporation (623.15M), less than Orthofix Medical Inc. (829.81M), greater than ProSomnus, Inc. Common Stock (40.81M), greater than Anika Therapeutics, Inc. (213.70M), less than Heska Corporation (1.26B),

Build a custom stock screener for MaxCyte, Inc. (MXCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MaxCyte, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MaxCyte, Inc. (MXCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MaxCyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.